Episurf Medical AB Series B
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more
Episurf Medical AB Series B (0QUT) - Total Liabilities
Latest total liabilities as of September 2021: Skr13.80 Million SEK
Based on the latest financial reports, Episurf Medical AB Series B (0QUT) has total liabilities worth Skr13.80 Million SEK as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Episurf Medical AB Series B - Total Liabilities Trend (2018–2020)
This chart illustrates how Episurf Medical AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Episurf Medical AB Series B Competitors by Total Liabilities
The table below lists competitors of Episurf Medical AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Helium Evolution Incorporated
PINK:HEEVF
|
USA | $10.29 Million |
|
NR Instant Produce Public Company Limited
BK:NRF
|
Thailand | ฿3.97 Billion |
|
Sampann Utpadan India Limited
NSE:SAMPANN
|
India | ₹1.01 Billion |
|
Peraso Inc
NASDAQ:PRSO
|
USA | $2.64 Million |
|
National Tyre & Wheel Limited
F:N37
|
Germany | €267.74 Million |
|
MOSTOSTAL Płock SA
WAR:MSP
|
Poland | zł81.67 Million |
Liability Composition Analysis (2018–2020)
This chart breaks down Episurf Medical AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Episurf Medical AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Episurf Medical AB Series B (2018–2020)
The table below shows the annual total liabilities of Episurf Medical AB Series B from 2018 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | Skr15.90 Million | -1.85% |
| 2019-12-31 | Skr16.20 Million | +62.00% |
| 2018-12-31 | Skr10.00 Million | -- |